Books, special issue and reviews


Peters, T. Jr. (1996). All about Albumin. Biochemistry, Genetics, and Medical Applications. Academic Press, San Diego, CA. 452 pp. This golden standard has a recent 2nd printing and is available on ebay. It can also be purchased via:

Otagiri M., Chuang, V.T.G., Maruyama, T & Kragh-Hansen, U. (Editors). (2013). Human serum albumin. New insights on its structural dynamics, functional impacts and pharmaceutical applications. Sojo University Publishing Center, Kumamoto, Japan. 510 pp. It has 20 chapters (reviews) updating on different molecular, clinical and pharmaceutical aspects of the protein.

Otagiri M. & Chuang, V.T.G.(Editors). (2016). Albumin in medicine. Pathological and clinical applications. Springer, Singapore. 277 pp. It has 11 chapters (reviews) updating on important biological and clinical aspects of human serum albumin.


Biochimica et Biophysica Acta, General Subjects published in December 2013 a special issue called “Serum Albumin” in honor of Theodore Peters, Jr. which was edited by Alan J. Stewart. The issue has 20 reviews covering different structural and functional aspects of albumin. It can be found on:


Kragh-Hansen, U., Chuang, V.T.G. & Otagiri, M. (2002). Practical aspects of the ligand-binding and enzymatic properties of human serum albumin. [139 refs]. Biol. Pharm. Bull. 25(6):695-704.

Curry, S. (2002). Beyond expansion: structural studies on the transport roles of human serum albumin. [35 refs]. Vox Sanguinis. 83:Suppl-9.

Kaysen, G.A. (2002). Serum albumin concentration in dialysis patients: why does it remain resistant to therapy? Kidney Int. Suppl. Nov(87):S92-98.

Koot, B.G., Houwen, R., Pot D.J. & Nauta, J. (2004) . Congenital analbuminaemia: biochemical and clinical implications. A case report and literature review. [38 refs]. Eur. J. Pediatr. Nov;163(11):664-670.

Quinlan, G.J. (2005). Albumin: Biochemical properties and therapeutic potential. Hepatology 41:1211-1219.

Chuang, V.T.G. & Otagiri, M. (2007). Recombinant human serum albumin. [100 refs.] Drugs of Today 43:547-56.

Minchiotti, L., Galliano, M., Kragh-Hansen , U. & Peters, T.Jr. (2008). Mutations and polymorphisms of the gene of the major human blood protein, serum albumin. [106 refs]. Hum. Mutat. Aug;29(8):1007-1116.

Elsadek, B. & Kratz, F. (2012). Impact of albumin on drug delivery – new applications on the horizon. [129 refs]. J. Control Release 157(1):4-28.

Fanali, G., di Masi, A., Trezza, V., Marino, M ., Fasano, M.& Ascenzi, P.G. (2012). Human serum albumin: from bench to bedside. Mol. Aspects Med. Jun;33(3):209-290.

Peters, T. Jr.& Stewart, A.J. (2013). Albumin research in the 21st century. [32 refs]. Biochim. Biophys. Acta Dec;1830(12):5351-5353.

Kragh-Hansen, U., Minchiotti, L., Galliano, M. & Peters, T. Jr. (2013). Human serum albumin isoforms: genetic and molecular aspects and functional consequences. [131 refs]. Biochim. Biophys. Acta Dec;1830(12):5405-5417.

Minchiotti, L., Galliano, M., Caridi, G., Kragh-Hansen, U. & Peters, T. Jr. (2013). Congenital analbuminaemia: molecular defects and biochemical and clinical aspects. [62 refs]. Biochim. Biophys. Acta Dec;1830(12):5494-5502.

Kragh-Hansen, U. (2013) . Molecular and practical aspects of the enzymatic properties of human serum albumin and of albumin-ligand complexes. [97 refs]. Biochim. Biophys. Acta Dec;1830(12):5535-5544.

Minchiotti, L., Caridi, G., Campagnoli, M., Galliano, M., Kragh-Hansen, U. & Peters, T. Jr. (2014). Molecular Genetics of Analbuminaemia. In: eLS. John Wiley & Sons Ltd, Chichester.

Kragh-Hansen, U., Galliano, M. & Minchiotti, L. (2017) Clinical, genetic, and protein structural aspects of familial dysalbuminemic hyperthyroxinemia and hypertriiodothyroninemia. [58 refs]. Front. Endocrinol. 8:297. doi: 10.3389/fendo.2017.00297.

Minchiotti, L., Caridi, G., Campagnoli, M., Lugani, F., Galliano, M., & Kragh-Hansen, U. (2019). Diagnosis, phenotype, and molecular genetics of congenital analbuminemia. [66 refs]. Front. Genet. 10:336. doi: 10.3389/gene.2019.00336.

REVISED 22.01.2021